Science
Mechanism of Action
This hexapeptide, primarily studied as Acetyl Hexapeptide-8, acts by interfering with nerve-muscle communication. It achieves this by mimicking the N-terminal end of SNAP-25, competing for a position within the SNARE complex. This destabilization reduces the release of acetylcholine, a neurotransmitter crucial for muscle contraction, thereby attenuating muscle movement and relaxing expression lines. Additionally, it may support collagen production and block calcium channels in neurons.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Demonstrated a 17% reduction in wrinkle depth around the eyes within 15 days in manufacturer in-vivo tests (for Argireline solution).
- 02 Achieved a 16.26% decrease in wrinkle depth after 28 days in a clinical study involving 14 volunteers (for Argireline solution in a cream).
- 03 Research by a Spanish University indicated increased skin moisturization and significant reductions in both the depth and width of wrinkles (for Argireline).
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Acetyl Hexapeptide-8 is highly water-soluble. Its stability against enzymatic degradation and skin penetration are enhanced by N-terminal acetylation and C-terminal amidation. Permeability through skin is significantly greater in acidic conditions (e.g., pH 2.7) compared to alkaline environments (pH 7.4).
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel deemed Acetyl Hexapeptide-8 (including Acetyl Hexapeptide-8 Amide) safe for use in cosmetics at concentrations up to 0.005%. Data at higher concentrations were considered insufficient. It is crucial to note that this safety information, along with clinical efficacy and mechanism data, pertains to Acetyl Hexapeptide-8, as direct data for 'Hexapeptide-78' was not identified in the research.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While research on Acetyl Hexapeptide-8 indicates significant efficacy in reducing wrinkle depth and improving moisturization, direct clinical and safety data specifically for Hexapeptide-78 is currently insufficient for a definitive assessment.
Related
Similar Ingredients
Finding similar ingredients…